David D'Andrea

Urologist, Oncologist, Researcher, Teacher - Medical University of Vienna, Father, Husband

[David D'Andrea @DavDandrea]

@BertrandTOMBAL @DrDelattre @VikramNarayan @SBoorjian @colin Can there be a proper control arm?

[David D'Andrea @DavDandrea]

Honored to be accepted as a member of the prestigious #IBCG
Looking forward to shape the future of #bladder #cancer
@UroDocAsh

[MedUni Wien @MedUni_Wien]

Wir gratulieren David D’Andrea, #Urologe an der #MedUniWien, zur Verleihung des renommierten Hans Marberger Awards. Der Preis wurde von @Uroweb im Rahmen des 39. Kongresses der European Association of #Urology verliehen. ⬇ https://t.co/4oTcLI9kS2

[EAU YAU Urothelial Carcinoma @EAU_YAUrotheli]

Our team #EAU24

👏👏👏 @DavDandrea for Winning the @Uroweb Hans Marberger🏆 with a multicentric RCT on #ERBT vs standard #TURBT

@eau_yuo @JGomezRivas @UroMoschini @f_delgiudice @E_Laukhtina @BenjaminPradere @frasor86 @gautiermarcq @Luca_Afferi @josedsh @RobertoContieri

[Juan Gómez Rivas @JGomezRivas]

Patients with very high-risk non muscle invasive #bladdercancer who receive adequate BCG therapy:

✅ Have a more favorable prognosis than predicted by EAU risk groups, especially among those with a sustained response

https://t.co/5y89CF4Ny3

@eau_yuo @EAUYAUrology @EAU_YAUrotheli @josedsh @UroMoschini @malvarezmaestro @DominguezEscrig @jteoh_hk @Daniel_Urologia @DrFelixGuerrero @MiguelSEncinas @dr_rajwa @Luca_Afferi

[European Association of Urology (EAU) @Uroweb]

UROtech24 is coming to Vienna in just over two weeks. If you're interested in all the latest in uro-technology, urolithiasis, imaging and robotics, you have until this Thursday to register at the discounted Late Fee! https://t.co/ypBZN3s1WT

[David D'Andrea @DavDandrea]

I do Office fulguration of small #bladdercancer with a 40ml 2% Xylocain instillation for 20min.
The fulguration is done with a 3fr uretheral catheter. I cut the tip and do a monopolar fulguration using the inner wire.
Probably the cheapest technique!

[David D'Andrea @DavDandrea]

@UroDocAsh EV + pembro #backtothefuture

[David D'Andrea @DavDandrea]

@Rainmaker1973 Probably also the future for pathologists @evacomperat

[David D'Andrea @DavDandrea]

Thank you @jteoh_hk for your inspiring talk! It’s a great honor to have you at the 9th #MJM @MedUni_Wien
Thank you for your friendship
#UroSoMe

[David D'Andrea @DavDandrea]

@DongNguyeb @EurUrolOncol @EurUrolOncol indeed attached as supplementary data 2
You can also find the protocol on https://t.co/Jf78JUFi4i NCT03718754

[David D'Andrea @DavDandrea]

@DongNguyeb @EurUrolOncol Thank you for your comment.
The primary outcome was pre defined and used for the power calculation, as it’s done in robust RCT.
What you are probably referring to, ist the explorative subgroup analysis

[David D'Andrea @DavDandrea]

@ReubenBenDavid1 @EurUrolOncol This is only relative to surgeon’s experience

[Simone Albisinni @albisinnidoc]

Un percorso per i nostri pazienti @AssPalinuro , per facilitare l’accesso a cure seguendo le linee guida @Uroweb #instillazione #robotica #eras #mdt @EAU_YAUrotheli

[EAU YAU Urothelial Carcinoma @EAU_YAUrotheli]

Our team joining forces in Marseille to program 2024 projects and studies!

#EMUC23

@UroMoschini @E_Laukhtina @albisinnidoc @f_delgiudice @frasor86 @agallioli @andreamari08 @josedsh @DrCanoVelasco @Luca_Afferi @wojciechpiotrk1 @gautiermarcq @eau_yuo @Uroweb @JGomezRivas

[David D'Andrea @DavDandrea]

The #ROGUE-1 has reached the 50% accrual
This great achievement goes to the extraordinary effort of the team and the lead of
@DrShariat @paolo_gontero

[Comprehensive Cancer Center Vienna (CCC) @CCCVienna]

➡️ Fortbildung (3DFP): #Urothelkarzinom und #Nierenzellkarzinom,
Cancer Update CCC Vienna,
📌19. 9. 2023, 17 Uhr, (Van Swieten Saal der MedUni Wien und online)
@DrShariat @schmidingerRCC Gregor Goldner, @KilianGust @DavDandrea @ozsoymeh
Info: https://t.co/N1RNs3zJNa
#CCCVienna

[David D'Andrea @DavDandrea]

Does the #eBLOC trial change your clinical practice?
@EurUrolOncol @EAU_Uroonco @Uroweb
https://t.co/lnjuyO5pZN

[David D'Andrea @DavDandrea]

In the #eBLOC trial we found en-bloc #TURB to achieve
Better resection quality ✅
Less complications ⚠️
Compared to conventional TURB https://t.co/ViI5SPUc9a

[EAU Edu Platform UROONCO @EAU_Uroonco]

📰 A recent study by Zlotta et al (Lancet Oncol. 2023) provides novel evidence supporting the role of trimodality therapy for muscle-invasive bladder cancer. Read the commentary by Dr. Mertens to find out more.👇

https://t.co/MuUPfJDda5

@LAUrology_NL

#BladderCancer #oncology